GEVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Synageva BioPharma Corp's quarterly trading assets declined from Jun. 2013 ($237.07 Mil) to Sep. 2013 ($218.61 Mil) but then increased from Sep. 2013 ($218.61 Mil) to Dec. 2013 ($346.60 Mil).
Synageva BioPharma Corp's annual trading assets increased from Dec. 2011 ($0.00 Mil) to Dec. 2012 ($195.07 Mil) and increased from Dec. 2012 ($195.07 Mil) to Dec. 2013 ($346.60 Mil).
Other assets that are traded in markets.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Synageva BioPharma Corp Annual Data
Synageva BioPharma Corp Quarterly Data